Overall, the studies investigating the role of IP and EP receptors in AD are mostly restricted to animal models, thus further studies are warranted to examine whether and how PGI2 and PGE2 are involved in the development and/or treatment of AD in humans. This evidence concerns the gene PTGIR and Alzheimer disease.